Publicaciones en colaboración con investigadores/as de Hospital General de Granollers (4)

2019

  1. Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain

    Journal of Dermatological Treatment, Vol. 30, Núm. 5, pp. 424-429

2018

  1. Corrigendum to “Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis” [89 (March (3)) (2018) 301–304] (Journal of Dermatological Science (2018) 89(3) (301–304), (S0923181117310083) (10.1016/j.jdermsci.2017.12.004))

    Journal of Dermatological Science

  2. Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis

    Cellular and Molecular Immunology, Vol. 15, Núm. 10, pp. 898-906

  3. Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis

    Journal of Dermatological Science